Healthcare Finance News February 11, 2020
Jeff Lagasse

Interest rates remain at historic lows and purchase price multipliers will likely be attractive to purchasers.

Mergers and acquisitions in healthcare have been occurring at a steady clip in recent years, and given several industry and demographic trends, that seems poised to continue, as organizations seek to consolidate to achieve scale and operational efficiencies.

It remains an active space in part because purchase price multiples — a measure of how costly a company or deal is to acquire — continue to be very attractive to sellers, and there continues to be an environment if low interest rates and a wealth of available investment dollars.

According to Mike Mauldin, head of the healthcare group at Regions Bank, uncertainty over this year’s...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Health System / Hospital, Mergers & Acquisitions / JV, Provider, Trends
Boehringer signs $1.3B deal with RNA biotech Ochre Bio to team up against MASH
Novant Health and CHS counter FTC bid to block hospital deal
Informatica says it's not for sale, following Salesforce's reported interest in $10 billion deal
With $380M deal, Bristol Myers Squibb ups the ante with cell therapy manufacturer Cellares
CHS to sell Tennessee hospital for $160M

Share This Article